{
    "clinical_study": {
        "@rank": "75682", 
        "arm_group": [
            {
                "arm_group_label": "Control Condition", 
                "arm_group_type": "No Intervention", 
                "description": "Control or Standard Care condition.  No intervention will be provided."
            }, 
            {
                "arm_group_label": "Texting + NRT Condition", 
                "arm_group_type": "Experimental", 
                "description": "Enrollment in NCI's Smokefree TXT Program 4 weeks of Nicotine Replacement Patches 4 weeks of Nicotine Replacement Gum Faxed Referral CT Smokers Quitline"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a pilot study to test the feasibility of conducting a text based smoking cessation\n      trial with Emergency Department patients who are smokers."
        }, 
        "brief_title": "Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Smoking", 
            "Tobacco Abstinence"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Emergencies", 
                "Smoking"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or older\n\n          -  have smoked >= 100 cigarettes lifetime\n\n          -  describe themselves as every or some day smokers\n\n          -  are able to give written informed consent\n\n          -  reside in Connecticut\n\n          -  own a cell phone with texting capability.\n\n        Exclusion Criteria:\n\n          -  inability to read or understand English\n\n          -  currently receiving formal tobacco dependence treatment\n\n          -  current use of tobacco cessation products (patch, gum, inhaler, nasal spray, lozenge,\n             e-cigarette)\n\n          -  currently using Zyban (bupropion), Wellbutrin (bupropion) or Chantix (varenicline)\n             for smoking cessation\n\n          -  current suicide or homicide risk\n\n          -  current psychotic disorder\n\n          -  life-threatening or unstable medical or psychiatric condition\n\n          -  does not have phone with CT area code and with texting capability\n\n          -  lacks capacity to give informed consent\n\n          -  leaving the ED against medical advice\n\n          -  pregnant, nursing, or trying to conceive\n\n          -  incarcerated\n\n          -  resides in an extended care facility"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081144", 
            "org_study_id": "0907005437-3", 
            "secondary_id": "R01CA141479"
        }, 
        "intervention": [
            {
                "arm_group_label": "Texting + NRT Condition", 
                "description": "The SmokeFreeTxt program is a library consisting of ~130 brief messages that can be proactively sent to smokers' cellphones using software developed and maintained by NCI. The message content is informed by principles of cognitive behavioral therapy. They are sent to smokers at random times of day (during normal waking hours), up to 5 messages per day.", 
                "intervention_name": "Smokefree TXT Program", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Texting + NRT Condition", 
                "description": "Subject will be given 4 weeks of Nicotine Replacement Patches, based on the amount he/she is smoking at baseline.", 
                "intervention_name": "nicotine replacement patches", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Texting + NRT Condition", 
                "description": "Subjects will be given 10 pieces of 2mg Nicotine Replacement Gum x 28 days.", 
                "intervention_name": "Nicotine Replacement Gum", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Texting + NRT Condition", 
                "description": "A faxed referral will be sent to the CT Smokers Quitline for the subject.", 
                "intervention_name": "Faxed Referral CT Smokers Quitline", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Standard Care Condition", 
            "Texting + NRT Condition"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "contact": {
                "email": "steven.bernstein@yale.edu", 
                "last_name": "Steven L Bernstein, MD", 
                "phone": "203-737-3574"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06510"
                }, 
                "name": "Yale New Haven Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study", 
        "overall_contact": {
            "email": "steven.bernstein@yale.edu", 
            "last_name": "Steven L Bernstein, MD", 
            "phone": "203-737-3574"
        }, 
        "overall_contact_backup": {
            "email": "junemarie.rosner@yale.edu", 
            "last_name": "June-Marie W Rosner, MA, MEd", 
            "phone": "203-737-3582"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Steven L Bernstein, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Study team will develop a survey to assess both subjects' satisfaction with the Smokefree TXT Program and ease of use.", 
            "measure": "Survey of satisfaction and usage of Smokefree TXT Program", 
            "safety_issue": "No", 
            "time_frame": "1 month post enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081144"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "7 day point prevalence abstinence will be assessed by asking if the subject has smoked even a puff in the past 7 days.", 
            "measure": "7 day point prevalence abstinence", 
            "safety_issue": "No", 
            "time_frame": "1 month post enrollment"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Cancer Institute (NCI)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "National Institutes of Health (NIH)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}